Vivos Inc.

Equities

RDGL

US92858K2042

Advanced Medical Equipment & Technology

Market Closed - OTC Markets Other stock markets 03:46:55 2024-05-24 pm EDT			5-day change	1st Jan Change
0.147 ^USD	+0.14%		-17.65%	+103.32%

May. 09	Vivos Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 18	Vivos Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Vivos Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024

May 09, 2024 at 05:31 pm EDT

Vivos Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 0.0045 million compared to USD 0.006 million a year ago. Net loss was USD 0.558539 million compared to USD 0.248318 million a year ago.

Latest news about Vivos Inc.

Vivos Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 09	CI
Vivos Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 18	CI
Vivos Inc. Announces Radiogel(TM) Precision Radionuclide Therapy(TM) Receives FDA Breakthrough Device Designation	Dec. 20	CI
Vivos Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 06	CI
Vivos Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-04	CI
Vivos Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-04	CI
Vivos Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-01	CI
Vivos Inc. Auditor Raises 'Going Concern' Doubt	23-02-28	CI
Vivos Inc Files A New Patent on Alternate Particles for Precision Radionuclide Therapy	23-01-11	CI
Vivos Inc. Files New Patent on Precision Radionuclide Therapy Support System Equipment	23-01-03	CI
Vivos Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-10-19	CI
Vivos Inc. Files A New Patent on the Hydrogel Component of Isopet®/Radiogel™	22-09-14	CI
Vivos Inc. Announces a New IsoPet® Precision Radionuclide Therapy Regional Clinic for Equine Therapy	22-08-16	CI
Vivos Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-07-25	CI
Vivos Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-10	CI
Vivos Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-07	CI
Vivos Inc. Auditor Raises 'Going Concern' Doubt	22-03-06	CI
Vivos Inc. Files Its Particle Patent in Several Countries	22-02-24	CI
Vivos Inc. Obtains Feedback from the FDA on Clinical Testing of RadioGel?	21-12-02	CI
Vivos Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-10-25	CI
Vivos Inc Signs A Memorandum of Understanding for A New Regional Clinic in Ny for Isopet Therapy	21-10-18	CI
Vivos Inc. Files Early Feasibility IDE Application with FDA for Radiogel™	21-09-20	CI
Vivos Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-02	CI
Vivos Inc Initiates Isopet® Therapy in Horses	21-06-24	CI
Vivos Inc Enhances Radiogel™ Manufacturing Process	21-05-24	CI

Chart Vivos Inc.

Duration

Period

More charts

Company Profile

Vivos Inc. is a radiation oncology medical device company. The Company is engaged in the development of its yttrium-90 (Y-90) based brachytherapy device, RadioGel, for the treatment of non-resectable tumors. RadioGel is a device for human therapy for non-resectable cancers in humans. It is a hydrogel liquid containing tiny Yttrium-90 phosphate microparticles that may be administered directly into a tumor. The Companyâs IsoPet division is focused on bringing RadioGel yttrium-90 precision radionuclide therapy to veterinary oncologists to treat dogs, cats and horses suffering from cancerous tumors. The IsoPet solutions division used university veterinary hospitals to demonstrate the safety and therapeutic effectiveness for different animal cancers. The Company is also engaged in developing a micro-injection system for small tumor therapy for treating cancerous thyroid lymph nodes.

Sector

Advanced Medical Equipment & Technology

More about the company

Income Statement Evolution

More financial data

Sector Medical Imaging Systems

	1st Jan change	Capi.
VIVOS INC.	+103.32%	60.39M
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.	-6.98%	14.42B
IRAY TECHNOLOGY COMPANY LIMITED	-42.66%	2.62B
SONOSCAPE MEDICAL CORP.	-14.27%	2.42B
BEIJING WANDONG MEDICAL TECHNOLOGY CO.,LTD.	-16.80%	1.38B
CORETAG, INC.	-.--%	1.12B
GUERBET	+90.26%	507M
NANO-X IMAGING LTD.	+32.34%	487M
DETECTION TECHNOLOGY OYJ	+27.01%	277M
DRTECH CORPORATION	+1.88%	234M

Medical Imaging Systems